Summary
Quest Diagnostics Incorporated (DGX) has filed a Form 8-K on April 2, 2007, reporting an amendment to its By-Laws, effective March 28, 2007. The primary change concerns the timeline for stockholders to submit nominations or proposals for inclusion in annual meetings. Previously, a specific window of January 1 to February 15 was required. The amendment now aligns the notice deadline for stockholder nominations and proposals with the deadline for including proposals in the company's proxy statement, as dictated by Rule 14a-8 of the Securities Exchange Act of 1934. This harmonization aims to standardize the process for stockholder engagement in annual meetings and proxy solicitations, potentially simplifying compliance for both the company and its shareholders.
Key Highlights
- 1Amendment to Quest Diagnostics' By-Laws approved on March 28, 2007.
- 2Effective date of the By-Law amendment is March 28, 2007.
- 3Key change is to Section 1.06 of the By-Laws regarding stockholder nominations and proposals.
- 4The amendment alters the deadline for stockholders to submit nominations or business for annual meetings.
- 5New deadline aligns with Rule 14a-8 of the Securities Exchange Act of 1934 for proxy statement inclusion.
- 6This change standardizes the timing for stockholder proposals, whether for inclusion in the proxy statement or for presentation at the meeting.
- 7Exhibit 3.1 contains the Amended and Restated By-Laws.